ARTICLE | Finance

Loose lips

Looking at value lost over three decades of the Clintons talking biotech

September 28, 2015 7:00 AM UTC

When it comes to Clinton proclamations that destroy value in the biotech sector, Hillary holds the market cap title but Bill still has the record in terms of one-week percent declines.

Last Monday, Hillary Clinton's announcement that she would address "price gouging" on specialty drugs sent the biotech sector into a tailspin. At week's end, the BioCentury 100 index was off 14%. All told, $145 billion of aggregate market cap evaporated from the sector last week, or 10% of the industry's total valuation...